Level C· Early human research exploring benefitsCohort StudyPubMedOpen access

Stemness and clinical performance of water-jet technology: A translational study in breast reconstruction.

De Francesco F., Zingaretti N., Quaglia D., Moro G., Pin AD., Cavaleri MP.

Cohort Study with a reported sample of 171, published in JPRAS Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
JPRAS Open (2025)
Country
Netherlands
Reported sample size
171
Source database
PubMed
PMID
41341966
PMCID
PMC12670530
DOI
10.1016/j.jpra.2025.10.010

Abstract (original English)

Autologous fat grafting has become integral to breast reconstruction, yet variability in graft retention continues to challenge its reliability. This study aimed to characterize the biological and clinical properties of adipose tissue harvested using Body-Jet water-assisted liposuction (WAL) technology. A cohort of 171 patients undergoing 206 lipofilling procedures was analyzed, alongside in vitro studies evaluating adipose-derived cell viability, proliferative capacity, and molecular profile. Lipoaspirates obtained using Body-Jet demonstrated high cellular viability, robust mesenchymal stem cell proliferation (doubling time ∼15 hours), and consistent trilineage differentiation (adipogenic, osteogenic, and chondrogenic). Gene expression and secretome analyses revealed a regenerative molecular signature, including balanced cytokine, growth factor, and extracellular matrix protein profiles. Clinically, the WAL approach was associated with low postoperative pain (mean NRS 3.17), minimal complications, and high patient satisfaction, as assessed using BREAST-Q outcomes. A significant correlation emerged between BMI and harvested fat volume, with no association between pain and BMI or donor site. These findings support the hypothesis that Body-Jet-based liposuction yields biologically viable and regenerative lipoaspirates, while offering favorable clinical tolerability. Although tran

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.